Transgene Alternatives & Competitors

12 companies similar to Transgene — Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invi...

Checkmate Pharmaceuticals

Pioneering advanced immunotherapies to amplify cancer treatment options and improve patien...

11-50 Series C $170.00M

Biotechnology Health and Wellness +2

Glycyx

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...

3 Series A $7.10M

San Francisco, United Sta...

Biopharma Biotechnology +1

Barinthus Biotherapeutics

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunother...

34 Acquired $146.66M

Oxford, United Kingdom

Biotechnology Health and Wellness +1

Imvax, Inc.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...

24 $253.70M

Philadelphia, United Stat...

Biotechnology Health and Wellness +1

Rival Readout

Competing with Transgene? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Biond Biologics Ltd

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...

43 Series C $32.00M

Israel

Biotechnology Health Care +1

Prokarium

LIVING CURES

16 $80.90M

London, United Kingdom

Biotechnology Health Care +1

Alpha Cancer Technologies Inc.

HARNESSING NATURE TO BEAT CANCER

Toronto, Canada

Biotechnology Pharmaceutical

Compare

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

121 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

MimiVax, Inc.

Disrupting Cancer with Immunotherapy

3 Venture round $16.55M

Buffalo, United States

Biopharma Biotechnology +1

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

PNP Therapeutics, Inc.

Clinical-stage biopharmaceuticals developing cancer treatment platform with proprietary pr...

3 Seed $2.49M

Biotechnology Health and Wellness +1

About Transgene

Transgene is a pioneering biotechnology company established in 1979, headquartered in France. The company focuses on advancing cancer treatment through its innovative immunotherapy solutions. With a slogan promoting "Immunotherapy against cancer," Transgene offers four clinical-stage products backed by its cutting-edge...

Services

Development of personalized therapeutic vaccines, Design and implementation of oncolytic virus therapies, Research and development in immunotherapy, Advanced engineering technology applications

Target Customers

Cancer patients, Pharmaceutical companies, Biotechnology researchers, Healthcare providers

Business keywords

Immunotherapy, Cancer Treatment, Clinical-stage Products, Invir.IO™ Platform, Myvac® Platform, Biopharmaceutical, Immunotherapeutic Products, Chronic Infectious Diseases, Clinical Trials, Clinical Batch Manufacturing, Oncology

Frequently Asked Questions

Companies similar to Transgene include Checkmate Pharmaceuticals, Glycyx, Barinthus Biotherapeutics, Imvax, Inc., Cybrexa Therapeutics. They work in Biotechnology and Pharmaceutical and share Transgene's focus on cancer treatment, immunotherapy and oncology.

Bounce Watch lists 12 companies that share Transgene's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Transgene: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Transgene Profile Checkmate Pharmaceuticals Alternatives Glycyx Alternatives Barinthus Biotherapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Transgene on 17 Sep 2025. The 12 companies listed here were last checked between 25 Jul 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.